ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 166 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,000 | -95.1% | 125 | -92.4% | 0.00% | -95.0% |
| Q3 2020 | $61,000 | +134.6% | 1,650 | +230.0% | 0.02% | +100.0% |
| Q2 2020 | $26,000 | +85.7% | 500 | +11.1% | 0.01% | +66.7% |
| Q1 2020 | $14,000 | -22.2% | 450 | +50.0% | 0.01% | -14.3% |
| Q4 2019 | $18,000 | +63.6% | 300 | 0.0% | 0.01% | +40.0% |
| Q3 2019 | $11,000 | -21.4% | 300 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $14,000 | +16.7% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $12,000 | -14.3% | 300 | 0.0% | 0.01% | -33.3% |
| Q4 2018 | $14,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |